NEW YORK (GenomeWeb) – Danish life sciences and diagnostics firm Exiqon today announced flat year over year revenues for the first quarter.

For the three months ended March 30, Exiqon reported total revenues of DKK 39 million ($5.9 million). Product revenue increased 7 percent on a currency neutral basis to DKK 30.1 million, while service revenue tumbled 31 percent on a currency neutral basis to DKK 4.6 million, due to market fluctuations. License and grant revenues also remained flat at DKK 4.4 million.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.